Intervention to Master Complex Fall Risk Situations in Persons With Multiple Sclerosis (STAR)

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorRegion Örebro County

About this trial

People with multiple sclerosis (MS) have a higher fall risk compared to older people and to the general population. A meta-analysis reported that 56% of those with mild to moderate MS, fell at least once during a 3-month period. The risk of falling seems to peak when the walking distance starts to be affected and when walking aids are introduced and the walking distance is as short as 100 m. Previous studies have identified a number of fall risk factors, both relating to MS- symptoms and contextual factors. In a study published in 2025, we reported the complexity of fallsituations and the interaction between triggering factors, contextual factors and activities and circumstances that occurred before the fall incidents . The symptoms when having MS varies between individuals as well as over time. I the planned randomised, controlled multicenter study we move forward, producing individual fallrisk analyses based upon the findings from the study published in 2025, and offer individual strategies. This has not been studied before. All participants will receive general information on how fall risk can be prevented. Those randomised to control group will be offered the intervention after ending of the study. The study will be conducted in two phases starting with an internal pilot study followed by a full scale randomized controlled trial (RCT).

Eligibility criteria

Qualifiers

Diagnosed with MS

Affected ability to walk du to MS according to the participant

At least one self-reported fall the last 3 months due to MS according to the participant

Disqualifiers

Unable to walk 100m even with walking device and/or pauses.

Apparently affected walking ability due to other conditions such as for example orthopedic or other neurological diseases.

Difficulty to answer questionnaires written in Swedish

Trial design

Treatments tested in this trial

  • Individual strategies

Treatment groups

80 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Region Örebro County

Lead sponsor

Institution of Medical Sciences, Örebro University

Collaborator

Region Gävleborg

Collaborator

Region Västmanland

Collaborator

Sormland County Council, Sweden

Collaborator